Theranostics 2022; 12(7):3582-3583. doi:10.7150/thno.72572 This issue

Erratum

Cardiomyocyte-Restricted Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) Deletion Leads to Lethal Dilated Cardiomyopathy Partly Through Drp1 Signaling: Erratum

Zhidan Chen1#, Yang Li1#, Ying Wang1#, Juying Qian1, Hong Ma1, Xiang Wang1, Guoliang Jiang1, Ming Liu1, Yanpeng An2, Leilei Ma1, Le Kang1, Jianguo Jia1, Chunjie Yang1, Guoping Zhang1, Ying Chen3, Wei Gao1, Mingqiang Fu1, Zheyong Huang1, Huiru Tang2, Yichun Zhu3, Junbo Ge1, Hui Gong1 Corresponding address, Yunzeng Zou1 Corresponding address

1. Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
2. State Key Laboratory of Genetic Engineering, Zhongshan Hospital and School of Life Sciences, Fudan University. International Centre for Molecular Phenomics, Collaborative Innovation Center for Genetics and Development, Shanghai 200438, China.
3. Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
# These authors contributed equally to this work.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Chen Z, Li Y, Wang Y, Qian J, Ma H, Wang X, Jiang G, Liu M, An Y, Ma L, Kang L, Jia J, Yang C, Zhang G, Chen Y, Gao W, Fu M, Huang Z, Tang H, Zhu Y, Ge J, Gong H, Zou Y. Cardiomyocyte-Restricted Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) Deletion Leads to Lethal Dilated Cardiomyopathy Partly Through Drp1 Signaling: Erratum. Theranostics 2022; 12(7):3582-3583. doi:10.7150/thno.72572. Available from https://www.thno.org/v12p3582.htm

File import instruction

Corrected-article in Theranostics, Volume 8, 627

 

In the original publication, errors were regrettably found in Fig. 4A. The mistake was made during the figure arrangement. In Fig. 4A, the original bands of GAPDH were misused twice in two different treatment groups. We have checked the original bands and corrected them. The correction is shown below. The authors declare the amendments do not change the results and conclusions of the paper.

 Figure 4 

Western blot analysis of LC3-II, PPARα, PPARδ, PGC1α and LC3b (LC3-I: the upper band; LC3-II: the down band) in heart tissue from diluent or tamoxifen-injected MCM or MCM/LRP6fl/fl mice.

Theranostics Image

(View in new window)

Author contact

Corresponding address Corresponding authors: Hui Gong, PhD or Yunzeng Zou, MD, PhD; Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai 200032, China. Email: gonghui2005edu.cn or zou.yunzengsh.cn


Published 2022-4-26